Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.12 trillion and total revenue of $110 billion.
Market Cap
1.12T
Revenue
110B
Profits
-41.37B
PE Ratio
n/a
Profit Margin
-37.61%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.25B | -0.89% | 1,785,347 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 66.11B | 3.09% | 1,165,717 | 14.92B |
| 3 | ARGX | argenx SE | 49.93B | 0.81% | 489,106 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.85B | 1.42% | 799,222 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 34.32B | 3.95% | 291,217 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.96B | 2.06% | 2,402,223 | - |
| 7 | RPRX | Royalty Pharma plc | 30.55B | 1.24% | 2,868,470 | 2.44B |
| 8 | INSM | Insmed Incorporated | 23.39B | 0.47% | 2,989,093 | 819.56M |
| 9 | ROIV | Roivant Sciences Ltd. | 23.20B | 14.89% | 17,010,029 | 8.26M |
| 10 | BNTX | BioNTech SE | 22.85B | 2.93% | 848,180 | 3.23B |
| 11 | INCY | Incyte Corporation | 19.39B | 1.55% | 1,066,321 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 19.09B | 5.25% | 4,777,770 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.45B | 5.96% | 5,519,414 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.00B | 0.66% | 863,714 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 14.99B | 1.41% | 498,650 | 998.25M |
| 16 | SMMT | Summit Therapeutics Inc. | 13.89B | 12.87% | 4,630,120 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.36B | 3.36% | 2,609,023 | 579.96M |
| 18 | EXEL | Exelixis, Inc. | 12.54B | 2.53% | 2,414,168 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.40B | 1.65% | 2,005,309 | 1.06B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 11.87B | 1.74% | 646,741 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.84B | 0.32% | 361,115 | 1.13B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.87B | 5.41% | 1,582,575 | 622.01M |
| 23 | CYTK | Cytokinetics, Incorporated | 10.69B | 3.03% | 2,379,503 | 105.82M |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 9.70B | 0.78% | 2,189,666 | 3.24B |
| 25 | ABVX | ABIVAX Société Anonyme | 9.54B | 5.43% | 1,242,492 | 5.37M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.36B | 4.68% | 268,532 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.90B | 2.98% | 197,357 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.43B | 3.74% | 24,815,743 | 140.98M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.18B | 0.36% | 1,426,103 | 1.51B |
| 30 | NUVL | Nuvalent, Inc. | 8.08B | 1.31% | 403,266 | - |
| 31 | TECH | Bio-Techne Corporation | 7.31B | 2.71% | 2,788,629 | 1.21B |
| 32 | IMVT | Immunovant, Inc. | 7.25B | 35.26% | 19,566,590 | - |
| 33 | CELC | Celcuity Inc. | 6.84B | 7.16% | 879,616 | - |
| 34 | PCVX | Vaxcyte, Inc. | 6.81B | -3.30% | 4,138,751 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.63B | 3.21% | 516,170 | 51.48M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.49B | 2.55% | 371,676 | 74.06M |
| 37 | CORT | Corcept Therapeutics Incorporated | 6.34B | 1.44% | 1,115,136 | 769.10M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 6.25B | 7.96% | 1,088,200 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.21B | 3.93% | 496,737 | 217.17M |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.13% | 906,258 | 15.00M |
| 41 | APGE | Apogee Therapeutics, Inc. | 6.10B | 3.99% | 766,775 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.91B | 1.36% | 553,895 | 569.61M |
| 43 | PTCT | PTC Therapeutics, Inc. | 5.89B | 1.01% | 1,093,379 | 827.11M |
| 44 | SRRK | Scholar Rock Holding Corporation | 5.80B | 1.72% | 912,981 | - |
| 45 | CGON | CG Oncology, Inc. | 5.71B | 2.31% | 767,699 | 5.07M |
| 46 | BLTE | Belite Bio, Inc | 5.64B | 2.62% | 252,498 | - |
| 47 | TGTX | TG Therapeutics, Inc. | 5.63B | 0.84% | 1,413,936 | 700.35M |
| 48 | COGT | Cogent Biosciences, Inc. | 5.63B | 5.36% | 2,035,164 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.29B | 1.17% | 1,045,347 | 7.50M |
| 50 | LEGN | Legend Biotech Corporation | 5.22B | 4.38% | 1,382,114 | 1.14B |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 4.85B | 3.56% | 676,999 | 1.34M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.68B | 2.02% | 1,724,384 | 4.10M |
| 53 | CAI | Caris Life Sciences, Inc. | 4.44B | 4.95% | 2,715,769 | 907.29M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.36B | 4.80% | 256,035 | 274.48M |
| 55 | MANE | Veradermics, Incorporated | 4.34B | 5.25% | 371,877 | - |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.18B | 6.02% | 1,271,699 | 22.57M |
| 57 | TVTX | Travere Therapeutics, Inc. | 4.04B | 2.91% | 1,595,058 | 536.20M |
| 58 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | 0.13% | 2,357,378 | 596.96M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.82B | 3.81% | 666,537 | 18.07M |
| 60 | ORKA | Oruka Therapeutics, Inc. | 3.66B | 5.51% | 1,428,216 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.59B | 2.29% | 1,704,815 | 1.10B |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 3.53B | 4.42% | 802,498 | - |
| 63 | ERAS | Erasca, Inc. | 3.46B | 7.75% | 6,351,164 | - |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.42B | 3.66% | 1,641,327 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.40B | 1.08% | 96,957 | 803.79M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.05B | 3.84% | 3,445,890 | 56.99M |
| 67 | DNLI | Denali Therapeutics Inc. | 2.99B | 3.98% | 1,379,663 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 2.99B | 4.35% | 797,068 | 236.00M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.90B | 10.30% | 1,932,439 | - |
| 70 | ALMS | Alumis Inc. | 2.81B | 2.37% | 761,764 | 8.40M |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.79B | 5.71% | 883,520 | 535.08M |
| 72 | BEAM | Beam Therapeutics Inc. | 2.70B | 2.96% | 2,137,013 | 164.01M |
| 73 | GPCR | Structure Therapeutics Inc. | 2.62B | 2.76% | 1,342,830 | - |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 2.61B | 4.70% | 739,104 | 225.27M |
| 75 | KLRA | Kailera Therapeutics, Inc. | 2.60B | 2.29% | 234,712 | - |
| 76 | IRON | Disc Medicine, Inc. | 2.56B | 4.62% | 453,957 | - |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 2.56B | 4.97% | 2,325,905 | 415.62M |
| 78 | ELVN | Enliven Therapeutics, Inc. | 2.55B | 4.21% | 638,454 | - |
| 79 | RLAY | Relay Therapeutics, Inc. | 2.49B | 7.87% | 6,519,414 | 10.68M |
| 80 | VERA | Vera Therapeutics, Inc. | 2.49B | 4.12% | 870,174 | - |
| 81 | IMNM | Immunome, Inc. | 2.44B | 9.51% | 1,958,235 | 4.02M |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.43B | 2.49% | 738,844 | 865.00K |
| 83 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | 9.22% | 4,305,975 | - |
| 84 | NKTR | Nektar Therapeutics | 2.34B | 2.83% | 744,167 | 55.63M |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.29B | 4.10% | 1,547,854 | 670.00M |
| 86 | DFTX | Definium Therapeutics, Inc. | 2.28B | 4.25% | 1,492,651 | - |
| 87 | KOD | Kodiak Sciences Inc. | 2.26B | 5.23% | 665,163 | - |
| 88 | ZLAB | Zai Lab Limited | 2.11B | 2.40% | 834,383 | 453.28M |
| 89 | NBTX | Nanobiotix S.A. | 2.08B | -6.58% | 96,288 | 38.27M |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | 2.25% | 1,347,832 | 298.30M |
| 91 | TYRA | Tyra Biosciences, Inc. | 1.99B | -1.12% | 1,148,887 | - |
| 92 | ADMA | ADMA Biologics, Inc. | 1.98B | -0.81% | 4,541,954 | 509.86M |
| 93 | TRVI | Trevi Therapeutics, Inc. | 1.97B | 4.83% | 1,262,738 | - |
| 94 | VRDN | Viridian Therapeutics, Inc. | 1.95B | 10.39% | 3,535,648 | 70.92M |
| 95 | PHVS | Pharvaris N.V. | 1.93B | 1.73% | 209,587 | - |
| 96 | STOK | Stoke Therapeutics, Inc. | 1.89B | 1.12% | 950,629 | 32.08M |
| 97 | MESO | Mesoblast Limited | 1.85B | -0.21% | 204,434 | 65.38M |
| 98 | AAPG | Ascentage Pharma Group International | 1.82B | 4.16% | 11,434 | 82.08M |
| 99 | HRMY | Harmony Biosciences Holdings, Inc. | 1.82B | 3.09% | 669,436 | 899.11M |
| 100 | ZYME | Zymeworks Inc. | 1.81B | 1.80% | 542,650 | 81.26M |
| 101 | VCEL | Vericel Corporation | 1.81B | 2.64% | 634,017 | 292.09M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.81B | 2.88% | 2,291,226 | 2.18B |
| 103 | LKFT | Lakefront Biotherapeutics NV | 1.80B | 2.82% | 146,249 | 1.20B |
| 104 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 3.98% | 1,028,359 | 217.17M |
| 105 | SION | Sionna Therapeutics, Inc. | 1.78B | 4.83% | 392,330 | - |
| 106 | OCUL | Ocular Therapeutix, Inc. | 1.76B | 0.50% | 4,664,766 | 52.04M |
| 107 | ANAB | AnaptysBio, Inc. | 1.75B | 0.52% | 444,626 | 232.39M |
| 108 | NTLA | Intellia Therapeutics, Inc. | 1.71B | 2.68% | 4,905,711 | 66.09M |
| 109 | RAPP | Rapport Therapeutics, Inc. | 1.71B | 4.10% | 260,068 | 20.00M |
| 110 | NRIX | Nurix Therapeutics, Inc. | 1.70B | 7.74% | 1,673,939 | 71.78M |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | 2.78% | 678,361 | 66.05M |
| 112 | CAPR | Capricor Therapeutics, Inc. | 1.68B | 7.76% | 1,123,640 | 11.13M |
| 113 | GENB | Generate Biomedicines, Inc. | 1.67B | 4.83% | 860,680 | 30.30M |
| 114 | SLS | SELLAS Life Sciences Group, Inc. | 1.67B | 18.18% | 18,441,637 | - |
| 115 | PVLA | Palvella Therapeutics, Inc. | 1.66B | 5.77% | 220,946 | - |
| 116 | OCS | Oculis Holding AG | 1.65B | -0.18% | 428,530 | 1.40M |
| 117 | INVA | Innoviva, Inc. | 1.64B | 2.35% | 937,978 | 420.69M |
| 118 | INBX | Inhibrx Biosciences, Inc. | 1.61B | 0.46% | 428,162 | 1.30M |
| 119 | IOVA | Iovance Biotherapeutics, Inc. | 1.58B | 2.31% | 8,937,099 | 285.61M |
| 120 | TSHA | Taysha Gene Therapies, Inc. | 1.58B | 5.78% | 3,128,264 | 7.47M |
| 121 | GLUE | Monte Rosa Therapeutics, Inc. | 1.58B | 6.09% | 911,596 | 42.95M |
| 122 | RXRX | Recursion Pharmaceuticals, Inc. | 1.57B | 3.86% | 13,162,530 | 66.41M |
| 123 | NUVB | Nuvation Bio Inc. | 1.57B | 6.37% | 4,824,330 | 143.05M |
| 124 | QURE | uniQure N.V. | 1.55B | -0.36% | 984,614 | 18.09M |
| 125 | ARDX | Ardelyx, Inc. | 1.55B | 2.96% | 2,793,960 | 427.68M |
| 126 | GHRS | GH Research PLC | 1.55B | 2.73% | 268,133 | - |
| 127 | NVAX | Novavax, Inc. | 1.52B | 4.16% | 4,949,591 | 596.34M |
| 128 | PGEN | Precigen, Inc. | 1.52B | 2.64% | 3,104,744 | 31.60M |
| 129 | IMTX | Immatics N.V. | 1.50B | 4.86% | 644,618 | 43.00M |
| 130 | IMCR | Immunocore Holdings plc | 1.50B | 2.11% | 535,985 | 412.81M |
| 131 | ATAI | AtaiBeckley Inc. | 1.50B | 3.28% | 3,458,862 | 3.49M |
| 132 | VIR | Vir Biotechnology, Inc. | 1.50B | 4.10% | 1,934,135 | 65.50M |
| 133 | MBX | MBX Biosciences, Inc. | 1.50B | 3.42% | 816,733 | - |
| 134 | URGN | UroGen Pharma Ltd. | 1.47B | 6.94% | 789,368 | 140.49M |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.46B | 0.46% | 180,034 | - |
| 136 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.15% | 5,543,683 | 114.48M |
| 137 | ABCL | AbCellera Biologics Inc. | 1.40B | 12.84% | 8,513,065 | 79.21M |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.39B | 2.33% | 347,605 | 20.00M |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.34B | 2.00% | 375,488 | - |
| 140 | BHVN | Biohaven Ltd. | 1.33B | 5.48% | 2,904,047 | - |
| 141 | FTRE | Fortrea Holdings Inc. | 1.30B | -0.07% | 876,927 | 2.71B |
| 142 | SVRA | Savara Inc. | 1.29B | 7.63% | 1,157,722 | - |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.27B | 4.09% | 454,446 | - |
| 144 | SEPN | Septerna, Inc. | 1.26B | 5.66% | 226,713 | 72.26M |
| 145 | MPLT | MapLight Therapeutics, Inc. | 1.26B | 2.70% | 196,648 | - |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.24B | 4.15% | 604,545 | - |
| 147 | ZBIO | Zenas BioPharma, Inc. | 1.23B | 9.64% | 568,911 | 10.00M |
| 148 | OLMA | Olema Pharmaceuticals, Inc. | 1.22B | 6.56% | 818,800 | - |
| 149 | WVE | Wave Life Sciences Ltd. | 1.19B | 0.81% | 4,643,131 | 71.80M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.17B | -0.28% | 181,017 | - |
| 151 | COAG | Hemab Therapeutics Holdings, Inc. | 1.16B | 3.30% | 161,849 | - |
| 152 | JBIO | Jade Biosciences, Inc. | 1.15B | 6.67% | 595,977 | - |
| 153 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.14B | 4.98% | 3,443,797 | 204.73M |
| 154 | DBVT | DBV Technologies S.A. | 1.11B | 0.16% | 108,153 | 5.74M |
| 155 | IVA | Inventiva S.A. | 1.07B | 4.68% | 159,835 | 7.94M |
| 156 | AKTS | Aktis Oncology, Inc. | 1.05B | 2.86% | 124,228 | 8.28M |
| 157 | EYPT | EyePoint, Inc. | 1.05B | 5.75% | 1,082,275 | 7.61M |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 1.03B | 6.00% | 2,187,478 | - |
| 159 | MNKD | MannKind Corporation | 1.00B | 9.80% | 5,175,749 | 360.78M |
| 160 | DRTS | Alpha Tau Medical Ltd. | 983.95M | 4.68% | 1,251,471 | - |
| 161 | LXRX | Lexicon Pharmaceuticals, Inc. | 981.47M | 3.76% | 1,700,036 | 69.64M |
| 162 | PHAT | Phathom Pharmaceuticals, Inc. | 942.84M | 4.12% | 1,005,338 | 204.89M |
| 163 | KURA | Kura Oncology, Inc. | 917.93M | 15.40% | 5,341,938 | 71.64M |
| 164 | PHAR | Pharming Group N.V. | 911.66M | 2.14% | 6,332 | 369.49M |
| 165 | OMER | Omeros Corporation | 896.01M | 3.43% | 1,052,838 | 9.89M |
| 166 | MGTX | MeiraGTx Holdings plc | 887.20M | 4.93% | 792,978 | 79.76M |
| 167 | CGEM | Cullinan Therapeutics, Inc. | 880.69M | 1.06% | 988,496 | - |
| 168 | JANX | Janux Therapeutics, Inc. | 878.17M | 4.27% | 1,256,993 | 13.73M |
| 169 | ORIC | ORIC Pharmaceuticals, Inc. | 870.58M | 5.52% | 980,277 | - |
| 170 | SANA | Sana Biotechnology, Inc. | 865.49M | 1.63% | 2,944,182 | - |
| 171 | ABUS | Arbutus Biopharma Corporation | 863.24M | 4.05% | 2,400,620 | 191.45M |
| 172 | TBPH | Theravance Biopharma, Inc. | 853.20M | 1.85% | 476,516 | 109.78M |
| 173 | VOR | Vor Biopharma Inc. | 842.59M | 10.05% | 1,424,156 | - |
| 174 | XNCR | Xencor, Inc. | 839.28M | 8.74% | 904,276 | 97.36M |
| 175 | SPTX | Seaport Therapeutics, Inc. | 836.78M | 0.77% | 266,055 | - |
| 176 | ANNX | Annexon, Inc. | 825.77M | 2.65% | 1,808,608 | - |
| 177 | AURA | Aura Biosciences, Inc. | 823.94M | 1.08% | 486,317 | - |
| 178 | CTMX | CytomX Therapeutics, Inc. | 809.85M | 2.20% | 2,349,388 | 35.54M |
| 179 | GERN | Geron Corporation | 808.32M | 3.28% | 8,387,521 | 196.12M |
| 180 | LBRX | LB Pharmaceuticals Inc | 804.67M | 2.90% | 177,256 | - |
| 181 | EVMN | Evommune, Inc. | 802.49M | 5.49% | 353,829 | 10.00M |
| 182 | ODTX | Odyssey Therapeutics, Inc. | 800.31M | 0.15% | 389,031 | 2.98M |
| 183 | AVTX | Avalo Therapeutics, Inc. | 799.13M | 0.12% | 1,316,551 | 59.00K |
| 184 | DRUG | Bright Minds Biosciences Inc. | 798.70M | 11.05% | 201,404 | - |
| 185 | SPRY | ARS Pharmaceuticals, Inc. | 774.57M | 8.79% | 1,625,576 | 98.99M |
| 186 | ABSI | Absci Corporation | 771.73M | 6.91% | 3,447,953 | 1.84M |
| 187 | RLMD | Relmada Therapeutics, Inc. | 752.05M | 1.99% | 763,926 | - |
| 188 | SGP | SpyGlass Pharma, Inc. | 731.71M | 3.25% | 37,947 | - |
| 189 | ANRO | Alto Neuroscience, Inc. | 728.40M | 1.61% | 211,728 | - |
| 190 | TENX | Tenax Therapeutics, Inc. | 706.54M | 4.53% | 327,890 | - |
| 191 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 705.09M | 1.03% | 461,379 | - |
| 192 | DSGN | Design Therapeutics, Inc. | 693.27M | 5.82% | 2,502,113 | - |
| 193 | ALLO | Allogene Therapeutics, Inc. | 655.79M | 0.53% | 5,201,370 | 22.00K |
| 194 | SLDB | Solid Biosciences Inc. | 636.97M | 6.41% | 1,059,420 | - |
| 195 | ACRS | Aclaris Therapeutics, Inc. | 632.68M | 1.80% | 993,107 | 8.37M |
| 196 | CBIO | Crescent Biopharma, Inc. | 628.36M | 2.33% | 107,803 | 11.88M |
| 197 | CRMD | CorMedix Inc. | 622.12M | 1.41% | 1,429,814 | 400.05M |
| 198 | ZVRA | Zevra Therapeutics, Inc. | 605.34M | 0.39% | 1,028,668 | 122.29M |
| 199 | ARVN | Arvinas, Inc. | 587.14M | 6.43% | 839,850 | 89.40M |
| 200 | EIKN | Eikon Therapeutics, Inc. | 577.12M | 0.19% | 236,602 | - |
| 201 | CADL | Candel Therapeutics, Inc. | 564.91M | 0.65% | 1,434,891 | - |
| 202 | MDXG | MiMedx Group, Inc. | 564.50M | 4.12% | 1,195,648 | 389.42M |
| 203 | TRAX | First Tracks Biotherapeutics, Inc. | 564.04M | -2.97% | 491,106 | - |
| 204 | CABA | Cabaletta Bio, Inc. | 560.89M | 5.20% | 3,290,659 | - |
| 205 | GYRE | Gyre Therapeutics, Inc. | 551.89M | -3.51% | 95,302 | 117.05M |
| 206 | VALN | Valneva SE | 549.16M | 2.78% | 62,453 | 180.25M |
| 207 | ALT | Altimmune, Inc. | 548.42M | 2.92% | 2,229,240 | 36.00K |
| 208 | TECX | Tectonic Therapeutic, Inc. | 544.19M | 5.68% | 180,768 | - |
| 209 | RIGL | Rigel Pharmaceuticals, Inc. | 533.23M | 1.84% | 308,810 | 299.77M |
| 210 | AGMB | AgomAb Therapeutics NV | 526.95M | 1.81% | 38,019 | - |
| 211 | XOMA | XOMA Royalty Corporation | 526.47M | 1.06% | 111,364 | 48.56M |
| 212 | KYTX | Kyverna Therapeutics, Inc. | 518.74M | -1.49% | 849,279 | - |
| 213 | STRO | Sutro Biopharma, Inc. | 515.76M | -1.71% | 373,999 | 99.61M |
| 214 | PRME | Prime Medicine, Inc. | 511.15M | 4.81% | 2,164,761 | 4.03M |
| 215 | PROK | ProKidney Corp. | 510.31M | 9.03% | 1,278,665 | 889.00K |
| 216 | DNA | Ginkgo Bioworks Holdings, Inc. | 504.31M | 4.89% | 691,919 | 151.40M |
| 217 | CLYM | Climb Bio, Inc. | 502.53M | 9.02% | 697,415 | - |
| 218 | CTNM | Contineum Therapeutics, Inc. | 500.60M | 4.94% | 202,419 | - |
| 219 | FBRX | Forte Biosciences, Inc. | 496.29M | 1.20% | 133,666 | - |
| 220 | PRTA | Prothena Corporation plc | 489.50M | 3.09% | 624,873 | 57.94M |
| 221 | IMMX | Immix Biopharma, Inc. | 473.93M | 0.90% | 644,145 | - |
| 222 | ACHV | Achieve Life Sciences, Inc. | 469.15M | 2.70% | 1,139,697 | - |
| 223 | STTK | Shattuck Labs, Inc. | 466.34M | 6.56% | 307,565 | 1.00M |
| 224 | OCGN | Ocugen, Inc. | 460.39M | 4.62% | 4,044,111 | 4.47M |
| 225 | UPB | Upstream Bio, Inc. | 457.67M | 4.73% | 593,019 | 3.32M |
| 226 | ANL | Adlai Nortye Ltd. | 454.40M | 6.17% | 262,726 | 5.00M |
| 227 | VTVT | vTv Therapeutics Inc. | 454.19M | 0.30% | 54,711 | 36.84M |
| 228 | PRLD | Prelude Therapeutics Incorporated | 452.60M | 5.39% | 386,068 | 16.72M |
| 229 | FDMT | 4D Molecular Therapeutics, Inc. | 442.78M | 0.71% | 523,447 | 88.24M |
| 230 | MNPR | Monopar Therapeutics Inc. | 435.09M | 17.66% | 337,752 | - |
| 231 | AUTL | Autolus Therapeutics plc | 431.15M | -0.61% | 924,897 | 92.62M |
| 232 | PRTC | PureTech Health plc | 426.13M | 1.99% | 7,177 | 4.66M |
| 233 | REPL | Replimune Group, Inc. | 426.07M | 9.79% | 6,041,664 | - |
| 234 | NGNE | Neurogene Inc. | 425.86M | 0.26% | 186,365 | 925.00K |
| 235 | FULC | Fulcrum Therapeutics, Inc. | 423.12M | 7.45% | 518,102 | 80.00M |
| 236 | ASMB | Assembly Biosciences, Inc. | 417.34M | -0.98% | 121,786 | 71.10M |
| 237 | OVID | Ovid Therapeutics Inc. | 413.56M | -0.42% | 915,779 | 7.12M |
| 238 | ADCT | ADC Therapeutics SA | 412.10M | 3.18% | 664,893 | 79.18M |
| 239 | SGMT | Sagimet Biosciences Inc. | 410.65M | 1.68% | 732,020 | - |
| 240 | IPSC | Century Therapeutics, Inc. | 405.80M | 6.13% | 496,299 | 109.16M |
| 241 | LXEO | Lexeo Therapeutics, Inc. | 402.03M | 14.29% | 1,834,910 | - |
| 242 | LYEL | Lyell Immunopharma, Inc. | 401.79M | 6.94% | 82,094 | 31.00K |
| 243 | ENTA | Enanta Pharmaceuticals, Inc. | 395.76M | -1.09% | 161,204 | 69.21M |
| 244 | EPRX | Eupraxia Pharmaceuticals Inc. | 391.44M | 1.27% | 214,081 | - |
| 245 | ZURA | Zura Bio Limited | 387.59M | 2.38% | 1,447,491 | - |
| 246 | ARTV | Artiva Biotherapeutics, Inc. | 380.93M | -8.30% | 1,052,181 | 251.00K |
| 247 | GLSI | Greenwich LifeSciences, Inc. | 378.51M | 3.84% | 113,553 | - |
| 248 | BNTC | Benitec Biopharma Inc. | 377.55M | 2.52% | 83,983 | - |
| 249 | OABI | OmniAb, Inc. | 374.03M | 8.86% | 1,058,195 | 28.94M |
| 250 | VNDA | Vanda Pharmaceuticals Inc. | 371.64M | 3.17% | 1,179,991 | 217.78M |
| 251 | LRMR | Larimar Therapeutics, Inc. | 368.47M | 6.01% | 1,927,419 | - |
| 252 | VSTM | Verastem, Inc. | 362.92M | -0.48% | 2,132,536 | 49.59M |
| 253 | CCCC | C4 Therapeutics, Inc. | 361.39M | 5.47% | 1,553,151 | 34.86M |
| 254 | IFRX | InflaRx N.V. | 359.39M | 2.95% | 777,011 | 33.82K |
| 255 | PBYI | Puma Biotechnology, Inc. | 355.79M | 2.64% | 224,155 | 227.18M |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 355.59M | 3.57% | 271,758 | 9.01M |
| 257 | CMPX | Compass Therapeutics, Inc. | 340.37M | 4.42% | 3,810,361 | 850.00K |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 338.69M | -0.10% | 238,893 | 51.00M |
| 259 | RZLT | Rezolute, Inc. | 336.38M | 3.87% | 896,503 | - |
| 260 | AVIR | Atea Pharmaceuticals, Inc. | 335.31M | 0.96% | 211,619 | - |
| 261 | IMRX | Immuneering Corporation | 324.78M | 2.66% | 630,447 | - |
| 262 | RCKT | Rocket Pharmaceuticals, Inc. | 324.30M | 1.71% | 2,619,281 | - |
| 263 | LCTX | Lineage Cell Therapeutics, Inc. | 321.59M | 7.50% | 1,916,956 | 14.78M |
| 264 | YDES | YD Bio Limited | 319.96M | -8.91% | 14,016 | 510.36K |
| 265 | IRD | Opus Genetics, Inc. | 317.03M | 4.23% | 540,638 | 11.98M |
| 266 | PALI | Palisade Bio, Inc. | 314.76M | 3.87% | 3,368,040 | - |
| 267 | NMRA | Neumora Therapeutics, Inc. | 314.22M | 2.99% | 1,074,443 | - |
| 268 | SRZN | Surrozen, Inc. | 310.72M | 6.34% | 92,810 | 7.49M |
| 269 | RGNX | REGENXBIO Inc. | 308.63M | 5.48% | 2,246,605 | 87.82M |
| 270 | IVVD | Invivyd, Inc. | 308.26M | 4.81% | 2,275,677 | 55.87M |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 308.21M | 2.69% | 176,108 | - |
| 272 | BCYC | Bicycle Therapeutics plc | 308.11M | 1.61% | 447,387 | 63.50M |
| 273 | ABEO | Abeona Therapeutics Inc. | 303.21M | 3.91% | 914,544 | 14.54M |
| 274 | NGEN | NervGen Pharma Corp. | 302.68M | 5.06% | 80,119 | - |
| 275 | NAUT | Nautilus Biotechnology, Inc. | 302.45M | - | 317,655 | - |
| 276 | NAGE | Niagen Bioscience, Inc. | 299.29M | 2.18% | 812,282 | 130.42M |
| 277 | ARMP | Armata Pharmaceuticals, Inc. | 297.96M | -4.02% | 67,387 | 5.20M |
| 278 | ELDN | Eledon Pharmaceuticals, Inc. | 296.84M | 7.26% | 917,688 | - |
| 279 | SLN | Silence Therapeutics plc | 294.74M | 7.97% | 170,101 | 839.00K |
| 280 | ACIU | AC Immune SA | 286.69M | 2.48% | 178,255 | 4.62M |
| 281 | IKT | Inhibikase Therapeutics, Inc. | 286.31M | 7.01% | 674,897 | 1.00 |
| 282 | MGNX | MacroGenics, Inc. | 283.48M | -1.33% | 836,362 | 157.08M |
| 283 | NVCT | Nuvectis Pharma, Inc. | 281.30M | 2.96% | 110,866 | - |
| 284 | CLLS | Cellectis S.A. | 268.62M | 0.83% | 40,348 | 75.11M |
| 285 | ALXO | ALX Oncology Holdings Inc. | 267.77M | 1.53% | 438,802 | - |
| 286 | TARA | Protara Therapeutics, Inc. | 267.53M | 9.68% | 704,350 | - |
| 287 | ZNTL | Zentalis Pharmaceuticals, Inc. | 264.10M | 4.80% | 1,378,409 | 26.87M |
| 288 | SABS | SAB Biotherapeutics, Inc. | 258.61M | 3.66% | 565,624 | 114.70K |
| 289 | CGEN | Compugen Ltd. | 255.77M | -0.92% | 265,467 | 72.66M |
| 290 | AVXL | Anavex Life Sciences Corp. | 254.85M | 3.00% | 880,525 | - |
| 291 | EDIT | Editas Medicine, Inc. | 254.56M | 5.69% | 1,373,895 | 38.69M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 238.33M | -0.50% | 93,238 | 32.72M |
| 293 | ALEC | Alector, Inc. | 235.37M | 0.47% | 898,476 | 18.42M |
| 294 | FHTX | Foghorn Therapeutics Inc. | 234.86M | 11.11% | 245,942 | 28.22M |
| 295 | CDXS | Codexis, Inc. | 234.51M | 4.88% | 905,168 | 78.09M |
| 296 | NERV | Minerva Neurosciences, Inc. | 234.34M | 15.37% | 414,805 | - |
| 297 | CAMP | Camp4 Therapeutics Corporation | 233.67M | 8.43% | 31,403 | 3.93M |
| 298 | CHRS | Coherus Oncology, Inc. | 232.92M | 2.03% | 702,242 | 46.88M |
| 299 | TNXP | Tonix Pharmaceuticals Holding Corp. | 231.14M | 5.76% | 221,974 | 17.56M |
| 300 | ADAG | Adagene Inc. | 227.95M | 1.03% | 41,747 | 7.67M |
| 301 | LENZ | LENZ Therapeutics, Inc. | 225.75M | 8.27% | 1,143,610 | 20.99M |
| 302 | TRDA | Entrada Therapeutics, Inc. | 217.64M | 6.90% | 440,630 | 5.74M |
| 303 | RNA | Atrium Therapeutics, Inc. | 217.58M | -1.78% | 168,123 | 36.68M |
| 304 | MDWD | MediWound Ltd. | 217.46M | 1.38% | 55,120 | 16.96M |
| 305 | KROS | Keros Therapeutics, Inc. | 217.31M | 10.80% | 521,808 | 33.18M |
| 306 | HELP | Cybin Inc. | 217.16M | 3.83% | 542,174 | - |
| 307 | FATE | Fate Therapeutics, Inc. | 214.47M | -2.65% | 2,878,428 | 6.32M |
| 308 | IPHA | Innate Pharma S.A. | 213.87M | 8.37% | 30,052 | 10.57M |
| 309 | SLGL | Sol-Gel Technologies Ltd. | 213.43M | 3.13% | 21,619 | 19.39M |
| 310 | VYGR | Voyager Therapeutics, Inc. | 211.47M | 0.57% | 990,638 | 36.49M |
| 311 | WHWK | Whitehawk Therapeutics, Inc. | 208.59M | 3.69% | 167,725 | 7.15M |
| 312 | UNCY | Unicycive Therapeutics, Inc. | 206.66M | 0.13% | 557,194 | - |
| 313 | BDTX | Black Diamond Therapeutics, Inc. | 206.29M | 20.00% | 7,943,248 | 70.00M |
| 314 | TLSA | Tiziana Life Sciences Ltd | 205.47M | 16.67% | 276,627 | - |
| 315 | CNTX | Context Therapeutics Inc. | 204.89M | 2.76% | 410,513 | - |
| 316 | MIST | Milestone Pharmaceuticals Inc. | 204.08M | 4.90% | 975,818 | 1.78M |
| 317 | HUMA | Humacyte, Inc. | 203.64M | 11.14% | 4,351,932 | 2.02M |
| 318 | NBP | NovaBridge Biosciences | 203.54M | 4.76% | 1,117,875 | - |
| 319 | NKTX | Nkarta, Inc. | 200.33M | 4.48% | 481,109 | - |
| 320 | CRBU | Caribou Biosciences, Inc. | 196.52M | 1.52% | 1,709,730 | 11.20M |
| 321 | ARCT | Arcturus Therapeutics Holdings Inc. | 193.85M | 1.94% | 428,388 | 54.71M |
| 322 | RNAC | Cartesian Therapeutics, Inc. | 191.57M | 7.06% | 178,101 | 1.78M |
| 323 | DTIL | Precision BioSciences, Inc. | 185.26M | 4.06% | 176,789 | 45.07M |
| 324 | CNTN | Canton Strategic Holdings, Inc. | 184.13M | -0.46% | 259,971 | - |
| 325 | ELTX | Elicio Therapeutics, Inc. | 183.41M | 8.72% | 91,235 | - |
| 326 | KPTI | Karyopharm Therapeutics Inc. | 179.96M | 6.83% | 658,496 | 151.12M |
| 327 | TNYA | Tenaya Therapeutics, Inc. | 175.36M | 2.62% | 1,991,560 | 225.00K |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 173.11M | -1.15% | 149,275 | 2.00M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 172.58M | 6.34% | 289,193 | - |
| 330 | ABOS | Acumen Pharmaceuticals, Inc. | 169.73M | 8.29% | 343,008 | - |
| 331 | ENLV | Enlivex Ltd. | 169.58M | -0.14% | 134,824 | - |
| 332 | MENS | Jyong Biotech Ltd. | 166.87M | -0.46% | 34,897 | - |
| 333 | ANTX | AN2 Therapeutics, Inc. | 165.22M | 0.88% | 68,672 | - |
| 334 | PLX | Protalix BioTherapeutics, Inc. | 161.95M | 5.79% | 702,599 | 76.38M |
| 335 | PLYX | Polaryx Therapeutics, Inc. | 160.02M | 10.46% | 174,776 | - |
| 336 | HRTX | Heron Therapeutics, Inc. | 159.96M | -0.35% | 2,120,296 | 150.71M |
| 337 | IMUX | Immunic, Inc. | 157.33M | -0.43% | 204,900 | - |
| 338 | SPRO | Spero Therapeutics, Inc. | 152.28M | 1.54% | 305,028 | 61.19M |
| 339 | HURA | TuHURA Biosciences, Inc. | 152.20M | -2.85% | 585,698 | - |
| 340 | PRQR | ProQR Therapeutics N.V. | 150.67M | - | 1,254,150 | 15.73M |
| 341 | KZIA | Kazia Therapeutics Limited | 148.21M | 7.37% | 109,704 | 1.27M |
| 342 | GUTS | Fractyl Health, Inc. | 146.16M | 12.75% | 1,702,827 | 3.00K |
| 343 | GALT | Galectin Therapeutics Inc. | 145.48M | 6.25% | 174,665 | - |
| 344 | KRRO | Korro Bio, Inc. | 144.37M | 9.40% | 150,166 | 3.84M |
| 345 | OKUR | OnKure Therapeutics, Inc. | 143.81M | 7.88% | 225,784 | - |
| 346 | TTRX | Turn Therapeutics Inc. | 141.79M | 4.62% | 34,400 | - |
| 347 | SPRB | Spruce Biosciences, Inc. | 139.21M | 6.77% | 60,040 | 697.00K |
| 348 | MOLN | Molecular Partners AG | 138.78M | - | 17,133 | 856.30K |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | 136.53M | -1.09% | 50,941 | 39.99K |
| 350 | AGEN | Agenus Inc. | 130.85M | 1.94% | 471,460 | 123.87M |
| 351 | CNTB | Connect Biopharma Holdings Limited | 130.56M | 5.48% | 201,292 | 233.00K |
| 352 | EQ | Equillium, Inc. | 130.25M | 16.71% | 309,613 | 4.39M |
| 353 | GNLX | Genelux Corporation | 130.12M | 4.64% | 100,233 | 8.00K |
| 354 | ACOG | Alpha Cognition Inc. | 128.25M | 1.55% | 46,142 | 10.83M |
| 355 | CRDF | Cardiff Oncology, Inc. | 125.80M | 4.55% | 1,768,203 | 525.00K |
| 356 | PYXS | Pyxis Oncology, Inc. | 125.71M | 4.71% | 555,894 | 13.86M |
| 357 | CGTX | Cognition Therapeutics, Inc. | 115.27M | 16.22% | 1,628,133 | - |
| 358 | ALPS | Alps Group Inc | 114.12M | -11.36% | 57,154 | 3.74M |
| 359 | KLRS | Kalaris Therapeutics, Inc. | 111.05M | 2.77% | 53,234 | - |
| 360 | RANI | Rani Therapeutics Holdings, Inc. | 108.80M | 23.25% | 2,457,947 | 3.17M |
| 361 | COYA | Coya Therapeutics, Inc. | 108.37M | 1.09% | 65,961 | 7.94M |
| 362 | CBUS | Cibus, Inc. | 108.32M | 9.23% | 296,250 | 4.29M |
| 363 | ENGN | enGene Therapeutics Inc. | 107.85M | 5.23% | 2,000,938 | - |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 103.42M | 7.69% | 31,084 | 37.16M |
| 365 | VANI | Vivani Medical, Inc. | 102.62M | 3.48% | 171,269 | - |
| 366 | INO | Inovio Pharmaceuticals, Inc. | 100.78M | 0.82% | 2,429,300 | 65.34K |
| 367 | PEPG | PepGen Inc. | 99.60M | 4.35% | 768,515 | - |
| 368 | NRXP | NRx Pharmaceuticals, Inc. | 98.11M | -1.98% | 946,766 | 2.29M |
| 369 | EDSA | Edesa Biotech, Inc. | 97.12M | -8.54% | 398,380 | - |
| 370 | BMEA | Biomea Fusion, Inc. | 96.16M | 9.02% | 1,139,214 | - |
| 371 | QTTB | Q32 Bio Inc. | 96.14M | -6.59% | 284,289 | 53.74M |
| 372 | ONCY | Oncolytics Biotech Inc. | 95.23M | 5.81% | 733,018 | - |
| 373 | PMN | ProMIS Neurosciences, Inc. | 95.06M | -0.47% | 6,121 | - |
| 374 | SEER | Seer, Inc. | 94.79M | - | 367,929 | 15.17M |
| 375 | AARD | Aardvark Therapeutics, Inc. | 93.59M | -1.83% | 173,205 | - |
| 376 | ALDX | Aldeyra Therapeutics, Inc. | 93.50M | 0.65% | 840,073 | - |
| 377 | PYPD | PolyPid Ltd. | 92.55M | 1.89% | 214,566 | - |
| 378 | ANIX | Anixa Biosciences, Inc. | 91.53M | 2.25% | 115,192 | - |
| 379 | PTHS | Pelthos Therapeutics Inc. | 90.97M | 0.41% | 58,721 | 27.70M |
| 380 | LONA | LeonaBio, Inc. | 90.37M | -4.66% | 22,823 | - |
| 381 | ICCC | ImmuCell Corporation | 89.38M | -3.14% | 25,022 | 29.93M |
| 382 | FBIO | Fortress Biotech, Inc. | 88.03M | 4.74% | 390,599 | 66.16M |
| 383 | CSBR | Champions Oncology, Inc. | 84.02M | 1.17% | 8,141 | 57.95M |
| 384 | OKYO | OKYO Pharma Limited | 83.97M | - | 32,062 | - |
| 385 | NRXS | NeurAxis, Inc. | 83.41M | - | 60,229 | 4.28M |
| 386 | ACET | Adicet Bio, Inc. | 81.49M | 7.03% | 154,069 | - |
| 387 | ATRA | Atara Biotherapeutics, Inc. | 80.44M | 0.43% | 80,391 | 23.14M |
| 388 | EXOZ | eXoZymes, Inc. | 79.70M | -1.05% | 5,798 | -700.00 |
| 389 | HYFT | MindWalk Holdings Corp. | 78.97M | 26.19% | 2,602,524 | 20.70M |
| 390 | MAIA | MAIA Biotechnology, Inc. | 78.43M | 4.88% | 455,634 | - |
| 391 | RLYB | Rallybio Corporation | 77.12M | 2.75% | 43,684 | 858.00K |
| 392 | OSTX | OS Therapies Incorporated | 76.93M | 3.98% | 542,838 | - |
| 393 | RNTX | Rein Therapeutics Inc. | 75.67M | -2.55% | 598,463 | - |
| 394 | ACRV | Acrivon Therapeutics, Inc. | 75.33M | 10.00% | 403,436 | - |
| 395 | PLRX | Pliant Therapeutics, Inc. | 74.30M | 4.35% | 1,568,560 | - |
| 396 | MCRB | Seres Therapeutics, Inc. | 74.18M | 2.96% | 20,102 | 1.15M |
| 397 | ATHE | Alterity Therapeutics Limited | 73.99M | 0.70% | 9,425 | 4.43M |
| 398 | XBIT | XBiotech Inc. | 73.02M | 1.05% | 18,067 | - |
| 399 | ANVS | Annovis Bio, Inc. | 70.68M | 5.15% | 3,942,864 | - |
| 400 | GANX | Gain Therapeutics, Inc. | 70.38M | 3.77% | 512,051 | - |
| 401 | PMVP | PMV Pharmaceuticals, Inc. | 69.86M | - | 88,322 | - |
| 402 | MNOV | MediciNova, Inc. | 68.42M | 0.72% | 20,243 | 596.64K |
| 403 | CUE | Cue Biopharma, Inc. | 66.51M | 0.64% | 180,234 | 32.73M |
| 404 | LIXT | Lixte Biotechnology Holdings, Inc. | 65.06M | 6.26% | 102,643 | - |
| 405 | IMMP | Immutep Limited | 62.27M | -6.92% | 854,973 | 5.28M |
| 406 | DWTX | Dogwood Therapeutics, Inc. | 61.46M | -0.54% | 51,489 | - |
| 407 | IBIO | iBio, Inc. | 61.44M | 13.33% | 734,263 | 300.00K |
| 408 | ENTX | Entera Bio Ltd. | 61.04M | -2.36% | 23,859 | 42.00K |
| 409 | IMA | ImageneBio, Inc. | 61.02M | 3.05% | 10,107 | 800.00K |
| 410 | FLNA | Filana Therapeutics, Inc. | 60.38M | 4.17% | 401,791 | - |
| 411 | ACTU | Actuate Therapeutics, Inc. | 60.05M | 4.58% | 56,253 | - |
| 412 | TCRX | TScan Therapeutics, Inc. | 59.78M | 3.27% | 587,673 | 9.14M |
| 413 | BYSI | BeyondSpring Inc. | 59.21M | 11.63% | 23,219 | 1.88M |
| 414 | IBO | Impact BioMedical Inc. | 58.01M | -0.06% | 29,064 | 39.00K |
| 415 | PDSB | PDS Biotechnology Corporation | 57.49M | 3.00% | 828,109 | - |
| 416 | CING | Cingulate Inc. | 56.72M | 5.47% | 247,787 | - |
| 417 | TIL | Instil Bio, Inc. | 54.39M | - | 87,715 | - |
| 418 | HYPD | Hyperion DeFi, Inc. | 53.70M | 10.04% | 552,783 | 1.04M |
| 419 | INKT | MiNK Therapeutics, Inc. | 53.41M | 3.57% | 36,210 | - |
| 420 | RADX | Radiopharm Theranostics Limited | 53.30M | -1.29% | 22,245 | 10.86M |
| 421 | ATYR | aTyr Pharma, Inc. | 52.03M | 9.86% | 3,412,927 | 190.00K |
| 422 | GOSS | Gossamer Bio, Inc. | 50.53M | 8.14% | 15,580,990 | 55.54M |
| 423 | XLO | Xilio Therapeutics, Inc. | 50.50M | 3.18% | 24,575 | 53.48M |
| 424 | KALA | KALA BIO, Inc. | 49.26M | 4.74% | 88,885 | - |
| 425 | ESLA | Estrella Immunopharma, Inc. | 48.64M | - | 5,733 | - |
| 426 | MGX | Metagenomi Therapeutics, Inc. | 48.56M | 3.20% | 223,715 | 22.33M |
| 427 | MREO | Mereo BioPharma Group plc | 45.12M | 18.78% | 5,576,573 | 500.00K |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 45.04M | 7.38% | 108,068 | - |
| 429 | PSTV | Plus Therapeutics, Inc. | 44.12M | 10.29% | 227,799 | 5.18M |
| 430 | TVGN | Tevogen Bio Holdings Inc. | 43.89M | 6.18% | 9,674 | - |
| 431 | NTRB | Nutriband Inc. | 42.91M | 2.32% | 7,163 | 2.04M |
| 432 | ATOS | Atossa Therapeutics, Inc. | 41.68M | 2.00% | 38,716 | - |
| 433 | LITS | Lite Strategy, Inc. | 40.73M | 2.75% | 242,430 | - |
| 434 | QNTM | Quantum BioPharma Ltd. | 40.11M | 11.57% | 476,193 | - |
| 435 | INMB | INmune Bio Inc. | 37.49M | - | 257,739 | 50.00K |
| 436 | NNVC | NanoViricides, Inc. | 36.90M | 1.89% | 628,765 | - |
| 437 | RNXT | RenovoRx, Inc. | 36.50M | 0.52% | 127,696 | 1.49M |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 36.48M | 1.74% | 78,824 | 90.00K |
| 439 | TVRD | Tvardi Therapeutics, Inc. | 36.12M | 3.77% | 51,764 | - |
| 440 | LTRN | Lantern Pharma Inc. | 35.53M | 2.59% | 351,683 | - |
| 441 | DARE | Daré Bioscience, Inc. | 34.90M | 3.56% | 309,213 | 1.16M |
| 442 | VERU | Veru Inc. | 34.83M | 2.84% | 19,719 | 16.89M |
| 443 | ALGS | Aligos Therapeutics, Inc. | 34.65M | 8.11% | 132,582 | 4.71M |
| 444 | NXTC | NextCure, Inc. | 34.45M | 4.60% | 10,023 | - |
| 445 | GRCE | Grace Therapeutics, Inc. | 33.73M | 1.40% | 264,973 | - |
| 446 | EVAX | Evaxion A/S | 33.36M | 0.50% | 14,644 | 7.53M |
| 447 | BOLD | Boundless Bio, Inc. | 31.83M | 1.43% | 100,187 | - |
| 448 | SNTI | Senti Biosciences Holdings, Inc. | 30.52M | 11.31% | 179,154 | 38.00K |
| 449 | CRVO | CervoMed Inc. | 30.00M | 12.11% | 97,238 | 2.09M |
| 450 | APLM | Apollomics, Inc. | 29.70M | -4.75% | 1,137 | 8.84M |
| 451 | LSTA | Lisata Therapeutics, Inc. | 28.72M | 1.92% | 16,279 | 170.00K |
| 452 | NRSN | NeuroSense Therapeutics Ltd. | 28.63M | 6.29% | 71,709 | - |
| 453 | OTLK | Outlook Therapeutics, Inc. | 28.56M | 19.53% | 6,313,825 | 333.14K |
| 454 | KYNB | Kyntra Bio, Inc. | 28.13M | 2.21% | 2,752 | 7.44M |
| 455 | BRNS | Barinthus Biotherapeutics plc | 28.06M | 0.51% | 50,873 | 14.97M |
| 456 | IGC | IGC Pharma, Inc. | 27.76M | -0.35% | 860,725 | 1.11M |
| 457 | BCTX | BriaCell Therapeutics Corp. | 27.59M | 10.54% | 472,462 | - |
| 458 | ABVC | ABVC BioPharma, Inc. | 27.18M | - | 78,871 | 797.92K |
| 459 | SKYE | Skye Bioscience, Inc. | 27.01M | 6.04% | 89,887 | - |
| 460 | DYAI | Dyadic International, Inc. | 26.88M | 0.58% | 12,348 | 3.81M |
| 461 | TPST | Tempest Therapeutics, Inc. | 26.68M | 4.49% | 103,884 | - |
| 462 | NEUP | Neuphoria Therapeutics Inc. | 26.58M | 3.35% | 50,618 | -13.27K |
| 463 | PTN | Palatin Technologies, Inc. | 26.37M | 2.24% | 8,856 | 12.88M |
| 464 | PLUR | Pluri Inc. | 26.13M | 3.17% | 12,739 | 1.08M |
| 465 | PLRZ | Polyrizon Ltd. | 25.36M | -3.08% | 43,646 | - |
| 466 | VTGN | Vistagen Therapeutics, Inc. | 25.35M | 1.54% | 390,663 | 789.00K |
| 467 | SER | Serina Therapeutics, Inc. | 25.33M | 5.59% | 115,877 | 130.00K |
| 468 | TRAW | Traws Pharma, Inc. | 24.54M | 1.89% | 938,809 | 2.73M |
| 469 | JSPR | Jasper Therapeutics, Inc. | 24.42M | 6.61% | 77,922 | - |
| 470 | GRDX | GridAI Technologies Corp. | 23.81M | -0.26% | 44,812 | - |
| 471 | CELU | Celularity Inc. | 23.80M | 2.37% | 276,167 | 26.55M |
| 472 | SNSE | Sensei Biotherapeutics, Inc. | 23.56M | 4.83% | 26,411 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 23.51M | 1.44% | 81,721 | 3.55M |
| 474 | ALLR | Allarity Therapeutics, Inc. | 23.04M | - | 135,908 | 345.00K |
| 475 | AEON | AEON Biopharma, Inc. | 22.70M | 0.91% | 36,957 | - |
| 476 | VYNE | VYNE Therapeutics Inc. | 22.55M | -0.66% | 124,950 | 454.00K |
| 477 | HOWL | Werewolf Therapeutics, Inc. | 21.29M | 2.24% | 1,033,331 | 1.14M |
| 478 | LGVN | Longeveron Inc. | 20.69M | 4.93% | 607,949 | 1.22M |
| 479 | CRIS | Curis, Inc. | 19.80M | 4.08% | 125,246 | 7.06M |
| 480 | XCUR | Exicure, Inc. | 19.06M | 3.46% | 14,016 | 500.00K |
| 481 | CLRB | Cellectar Biosciences, Inc. | 18.57M | 3.59% | 314,510 | - |
| 482 | KTTA | Pasithea Therapeutics Corp. | 18.01M | 2.76% | 248,505 | - |
| 483 | LPCN | Lipocine Inc. | 17.98M | 1.82% | 65,184 | 2.00M |
| 484 | QNCX | Quince Therapeutics, Inc. | 17.60M | 0.93% | 1,267,235 | - |
| 485 | NCEL | NewcelX Ltd. | 17.50M | 2.20% | 4,905 | - |
| 486 | PASG | Passage Bio, Inc. | 16.68M | 2.36% | 33,171 | - |
| 487 | OSRH | OSR Holdings, Inc. | 16.56M | -1.94% | 1,050,789 | 2.63M |
| 488 | HCWB | HCW Biologics Inc. | 16.36M | 129.25% | 195,715,714 | 6.59M |
| 489 | CVKD | Cadrenal Therapeutics, Inc. | 15.88M | 3.82% | 60,709 | - |
| 490 | ICU | SeaStar Medical Holding Corporation | 15.87M | 2.06% | 55,883 | 1.44M |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 15.72M | 4.66% | 917,029 | 5.61M |
| 492 | GDTC | CytoMed Therapeutics Limited | 15.62M | 9.09% | 38,007 | 669.28K |
| 493 | INAB | IN8bio, Inc. | 15.46M | 8.28% | 86,400 | - |
| 494 | COCP | Cocrystal Pharma, Inc. | 15.30M | -3.48% | 104,284 | 225.00K |
| 495 | MTVA | MetaVia Inc. | 14.93M | 53.72% | 61,950,070 | - |
| 496 | HIND | Vyome Holdings, Inc. | 14.81M | 4.98% | 22,581 | 152.72K |
| 497 | GNTA | Genenta Science S.p.A. | 14.58M | -0.80% | 38,759 | - |
| 498 | LEXX | Lexaria Bioscience Corp. | 14.41M | 0.73% | 143,079 | 368.00K |
| 499 | TOVX | Theriva Biologics, Inc. | 13.77M | 12.40% | 3,103,086 | 300.00K |
| 500 | ERNA | Ernexa Therapeutics Inc. | 13.29M | -0.44% | 78,569 | 1,000.00 |